MILOPHENE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Milophene, and when can generic versions of Milophene launch?
Milophene is a drug marketed by Granata Bio and is included in one NDA.
The generic ingredient in MILOPHENE is clomiphene citrate. There are sixteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the clomiphene citrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Milophene
A generic version of MILOPHENE was approved as clomiphene citrate by COSETTE on August 30th, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MILOPHENE?
- What are the global sales for MILOPHENE?
- What is Average Wholesale Price for MILOPHENE?
Summary for MILOPHENE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 120 |
| Clinical Trials: | 1 |
| Patent Applications: | 72 |
| DailyMed Link: | MILOPHENE at DailyMed |
Recent Clinical Trials for MILOPHENE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Weill Medical College of Cornell University | Phase 2 |
US Patents and Regulatory Information for MILOPHENE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Granata Bio | MILOPHENE | clomiphene citrate | TABLET;ORAL | 072196-001 | Dec 20, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
